BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/13/2022 7:31:00 AM | Browse: 311 | Download: 887
 |
Received |
|
2021-12-06 12:29 |
|
Peer-Review Started |
|
2021-12-06 12:32 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-01-08 08:27 |
|
Revised |
|
2022-01-12 15:11 |
|
Second Decision |
|
2022-06-08 03:14 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2022-06-17 21:24 |
|
Articles in Press |
|
2022-06-17 21:24 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-07-04 08:08 |
|
Publish the Manuscript Online |
|
2022-07-13 07:31 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Basic Study |
| Article Title |
Bifidobacterium infantis regulates the programmed cell death 1 pathway and immune response in mice with inflammatory bowel disease
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Lin-Yan Zhou, Ying Xie and Yan Li |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Doctoral Start-up Foundation of Liaoning Province |
2021-BS-114 |
|
| Corresponding Author |
Yan Li, PhD, Chief Doctor, Professor, Department of Gastroenterology, Shengjing Hospital of China Medical University, No. 36 Sanhao Road, Heping District, Shenyang 110004, Liaoning Province, China. liy@sj-hospital.org |
| Key Words |
Bifidobacterium infantis; Enteritis; Programmed cell death ligand; T-Lymphocytes |
| Core Tip |
Bifidobacterium infantis (B. infantis) can be used as a therapeutic agent to treat inflammatory bowel disease. It regulates the intestinal microbiota, alleviates inflammation, and regulates the immune response. We found that B. infantis increases the expression of forkhead box protein 3 (Foxp3) and the proliferation of Foxp3+ T cells, and activates the programmed cell death 1 (PD-1)/ PD ligand 1 pathway. |
| Publish Date |
2022-07-13 07:31 |
| Citation |
Zhou LY, Xie Y, Li Y. Bifidobacterium infantis regulates the programmed cell death 1 pathway and immune response in mice with inflammatory bowel disease. World J Gastroenterol 2022; 28(26): 3164-3176 |
| URL |
https://www.wjgnet.com/1007-9327/full/v28/i26/3164.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v28.i26.3164 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
